Dr. David Weinstein, MD

Dr. Weinstein practices at Urology Group of Florida in Delray Beach, Florida.

Dr. Weinstein's NPI, 1093765927, was assigned on May 11, 2006. Dr. Weinstein graduated from Icahn School Of Medicine At Mount Sinai in 1985. Dr. Weinstein holds Florida license ME0057846.

Dr. Weinstein's primary practice is Urology Group of Florida, at 5350 W Atlantic Ave, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 496-4444.

Dr. Weinstein's primary practice is Urology Group of Florida in Delray Beach, Florida. Dr. Weinstein is also affiliated with HCA Florida JFK Hospital. The medical group on file is Urology Group of Florida. Dmand AI also links Dr. Weinstein to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinstein practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Weinstein's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Weinstein is board certified in urology by the American Board of Urology. Dr. Weinstein is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Weinstein treats.

CMS data shows 7,105 Medicare services from Dr. Weinstein across 27 procedure codes in 2024, for 964 Medicare patients. Medicare paid $295,056 for them.

CMS counts 964 Medicare patients who saw Dr. Weinstein in 2024. The largest group is 75 to 84, with 450 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weinstein's median patient age at 74, with 24% women.

In 2024, Dr. Weinstein wrote 1,945 Medicare Part D claims for 586 patients. 94% of them were for generic drugs. CMS names the drug for 1,850 of them, across 20 drugs with 11 or more claims each, at $104,587 in total drug cost. In 2023, CMS named 1,701 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Weinstein for performance year 2024, reported individually. Dr. Weinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Weinstein, published from 2020 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Blood Glucose, Glucose-6-Phosphatase and Glycogen Storage Disease Type I. Dr. Weinstein has published most often in Orphanet J Rare Dis. Dr. Weinstein's most frequent co-authors are David Adam Weinstein, MD, Rebecca Diane Riba-Wolman, MD and Rosemary Jackson, MD, MPH.

CMS Open Payments shows 460 general payments to Dr. Weinstein from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Astellas Pharma US Inc paid the most, $1,579.

Dmand AI lists 3 awards for Dr. Weinstein, most recently Hero of Medicine award in 2016.

Dr. Weinstein graduated from Icahn School Of Medicine At Mount Sinai in 1985. Dr. Weinstein is a member of ACS.

Dr. Weinstein is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.